Bio Rad Laboratories Inc
BIO280.850USD
-1.410-0.50%
交易中 （美東）報價延遲15分鐘
7.60B總市值
23.81本益比TTM
關於 Bio Rad Laboratories Inc 公司
Bio-Rad Laboratories, Inc. 致力於爲生命科學研究和臨牀診斷市場開發、製造和營銷一系列產品。該公司提供一系列產品和系統，用於分離複雜的化學和生物材料並識別、分析和純化其成分。該公司通過兩個部門運營：生命科學和臨牀診斷。生命科學部門開發、製造和營銷用於生物研究、生物製藥生產過程、食品檢測制度和科學教育的儀器、系統、試劑和消耗品。其臨牀診斷部門設計、製造、營銷和支持測試系統、信息系統、測試套件和專門的質量控制，爲全球診斷市場的臨牀實驗室提供服務。這些產品銷往醫院實驗室、診斷參考實驗室、輸血實驗室和醫生辦公室實驗室。
公司簡介
公司代碼BIO
公司名稱Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOMr. Norman D. Schwartz
員工數量7700
證券類型Ordinary Share
年結日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NYSE Consolidated
國家United States of America
郵編94547
電話15107247000
網址https://www.bio-rad.com/
公司代碼BIO
上市日期Mar 17, 1980
CEOMr. Norman D. Schwartz
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
447.98K
+1.17%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
1.32K
+80.52%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Ms. Allison Schwartz
Ms. Allison Schwartz
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
447.98K
+1.17%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
1.32K
+80.52%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
241.70M
41.29%
Europe
199.80M
34.13%
APAC
104.10M
17.78%
Other
39.80M
6.80%
業務
地區
暫無數據
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
First Eagle Investment Management, L.L.C.
11.45%
The Vanguard Group, Inc.
8.38%
Alice N. Schwartz Revocable Trust
8.10%
BlackRock Institutional Trust Company, N.A.
7.02%
Dimensional Fund Advisors, L.P.
4.55%
其他
60.51%
持股股東
持股股東
佔比
First Eagle Investment Management, L.L.C.
11.45%
The Vanguard Group, Inc.
8.38%
Alice N. Schwartz Revocable Trust
8.10%
BlackRock Institutional Trust Company, N.A.
7.02%
Dimensional Fund Advisors, L.P.
4.55%
其他
60.51%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
41.56%
Investment Advisor
36.74%
Individual Investor
8.25%
Corporation
8.10%
Hedge Fund
7.05%
Research Firm
1.63%
Pension Fund
1.23%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.64%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1116
24.14M
109.77%
-3.54M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
2023Q1
1200
23.34M
95.18%
-1.09M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
First Eagle Investment Management, L.L.C.
2.29M
10.36%
+728.07K
+46.49%
Apr 30, 2025
The Vanguard Group, Inc.
1.90M
8.59%
-10.12K
-0.53%
Mar 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.04%
-3.19K
-0.18%
Feb 24, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
7.42%
-4.83K
-0.29%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.04K
3.96%
+130.92K
+17.55%
Mar 31, 2025
Schwartz (Alice N)
951.13K
4.3%
+2.20K
+0.23%
Feb 24, 2025
Veritas Asset Management LLP
913.12K
4.12%
-63.70K
-6.52%
Mar 31, 2025
Ariel Investments, LLC
724.66K
3.27%
+164.14K
+29.28%
Mar 31, 2025
EARNEST Partners, LLC
599.62K
2.71%
-18.43K
-2.98%
Mar 31, 2025
State Street Global Advisors (US)
694.52K
3.14%
+4.36K
+0.63%
Mar 31, 2025
查看更多
持股ETF
更新時間: 9月6日 週六
更新時間: 9月6日 週六
機構名稱
佔比
Gotham 1000 Value ETF
0%
Invesco Russell 1000 Equal Weight ETF
0%
WisdomTree US MidCap Fund
0%
Invesco S&P MidCap 400 QVM Multi-factor ETF
0%
SPDR S&P 500 ETF
0%
Dimensional US Core Equity 1 ETF
0%
VanEck Morningstar ESG Moat ETF
0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
0%
ROBO Global Healthcare Technology & Innovation ETF
0%
SPDR Portfolio S&P 500 Value ETF (SPYV)
0%
查看更多
Gotham 1000 Value ETF
佔比0%
Invesco Russell 1000 Equal Weight ETF
佔比0%
WisdomTree US MidCap Fund
佔比0%
Invesco S&P MidCap 400 QVM Multi-factor ETF
佔比0%
SPDR S&P 500 ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
VanEck Morningstar ESG Moat ETF
佔比0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
佔比0%
ROBO Global Healthcare Technology & Innovation ETF
佔比0%
SPDR Portfolio S&P 500 Value ETF (SPYV)
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
